These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

39 related articles for article (PubMed ID: 825930)

  • 1. Discriminative properties of narcotic antagonists.
    Holtzman SG; Shannon HE; Schaefer GJ
    Psychopharmacol Commun; 1976; 2(4):315-8. PubMed ID: 825930
    [No Abstract]   [Full Text] [Related]  

  • 2. Discriminative effects of narcotic agonists and antagonists in the rat and squirrel monkey [proceedings].
    Holtzman SG; Shannon E; Schaefer GJ
    Psychopharmacol Bull; 1977 Jan; 13(1):37-8. PubMed ID: 402009
    [No Abstract]   [Full Text] [Related]  

  • 3. Self administration: positive and negative reinforcing properties of morphine antagonists in rhesus monkeys.
    Hoffmeister F; Wuttke W
    Adv Biochem Psychopharmacol; 1973; 8(0):361-9. PubMed ID: 4212335
    [No Abstract]   [Full Text] [Related]  

  • 4. Further characterization of the three-choice morphine, cyclazocine and saline discrimination paradigm: opioids with agonist and antagonist properties.
    White JM; Holtzman SG
    J Pharmacol Exp Ther; 1983 Jan; 224(1):95-9. PubMed ID: 6336785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quaternary naltrexone: evidence for the central mediation of discriminative stimulus effects of narcotic agonists and antagonists.
    Valentino RJ; Herling S; Woods JH; Medzihradsky F; Merz H
    J Pharmacol Exp Ther; 1981 Jun; 217(3):652-9. PubMed ID: 6262493
    [No Abstract]   [Full Text] [Related]  

  • 6. Dietary cadmium exposure alters characteristics of training, substitution, and tolerance when morphine is used as a discriminative stimulus.
    Nation JR; Miller DK; Bratton GR
    Neurotoxicology; 2000 Aug; 21(4):553-67. PubMed ID: 11022863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aversive properties of nalorphine and naloxone in morphine-dependent rhesus monkeys.
    Goldberg SR; Hoffmeister F; Schlichting U; Wuttke W
    J Pharmacol Exp Ther; 1971 Nov; 179(2):268-76. PubMed ID: 5002481
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of narcotics and narcotic antagonists on operant behavior.
    McMillan DE
    Adv Biochem Psychopharmacol; 1973; 8(0):345-59. PubMed ID: 4604406
    [No Abstract]   [Full Text] [Related]  

  • 9. Discriminative stimulus effects of acute morphine followed by naltrexone in the squirrel monkey: a further characterization.
    White DA; Holtzman SG
    J Pharmacol Exp Ther; 2005 Jul; 314(1):374-82. PubMed ID: 15843500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereospecific aversive property of narcotic antagonists in morphine-free rats.
    Stolerman IP; Pilcher CW; D'Mello GD
    Life Sci; 1978 May; 22(19):1755-62. PubMed ID: 672425
    [No Abstract]   [Full Text] [Related]  

  • 11. [The discriminative stimulus properties of naloxone during dissociative learning in a Y maze in morphine-dependent rats].
    Bespalov AIu; Medvedev IO; Dravolina OA; Zvartau EE
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1999; 49(1):96-105. PubMed ID: 10330710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discriminative stimulus effects of l-alpha-acetylmethadol (LAAM), buprenorphine and methadone in morphine-treated rhesus monkeys.
    Brandt MR; Cabansag SR; France CP
    J Pharmacol Exp Ther; 1997 Aug; 282(2):574-84. PubMed ID: 9262317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The discriminative stimulus properties of morphine in female rats chronically depleted of dopamine.
    Spencer RM; Rosecrans JA
    Res Commun Chem Pathol Pharmacol; 1977 May; 17(1):1-14. PubMed ID: 877397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Classification of narcotics on the basis of their reinforcing, discriminative, and antagonist effects in rhesus monkeys.
    Woods JH; Young AM; Herling S
    Fed Proc; 1982 Feb; 41(2):221-7. PubMed ID: 7037459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Agmatine inhibits morphine-induced drug discrimination in rats.
    Su RB; Ren YH; Liu Y; Ding T; Lu XQ; Wu N; Liu ZM; Li J
    Eur J Pharmacol; 2008 Sep; 593(1-3):62-7. PubMed ID: 18657533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute opioid pretreatment potentiates naltrexone-induced drinking suppression in water-deprived rats.
    White DA; Holtzman SG
    J Pharmacol Exp Ther; 2001 Jul; 298(1):156-64. PubMed ID: 11408537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions of narcotic antagonists with receptor sites.
    Goldstein A
    Adv Biochem Psychopharmacol; 1973; 8(0):471-81. PubMed ID: 4212101
    [No Abstract]   [Full Text] [Related]  

  • 18. Discriminative properties of morphine that modulate associations between tastes and lithium chloride.
    Martin GM; Gans M; van der Kooy D
    J Exp Psychol Anim Behav Process; 1990 Jan; 16(1):56-68. PubMed ID: 2154527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opiate agonist-antagonist interactions: application of a three-key drug discrimination procedure.
    France CP; Woods JH
    J Pharmacol Exp Ther; 1985 Jul; 234(1):81-9. PubMed ID: 4009506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aversive properties of narcotic antagonists in rats.
    Stolerman IP; Pilcher CW; D'Mello G
    Neuropharmacology; 1978 Jun; 17(6):427. PubMed ID: 673159
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.